Merck & Company (MRK)
89.00 x 100 89.30 x 100
Post-market by (Cboe BZX)
89.23 +1.63 (+1.86%) 03/28/25 [NYSE]
89.00 x 100 89.30 x 100
Post-market 89.06 -0.17 (-0.19%) 19:55 ET
for Fri, Mar 28th, 2025
Results
download Want to compare other data? Select FieldsSymbol | MRK | LLY | JNJ | ABBV | NVO |
Company | Merck & Company | Eli Lilly and Company | Johnson & Johnson | Abbvie Inc | Novo Nordisk A/S ADR |
Price Information | |||||
Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
Open | 88.20 | 820.00 | 163.59 | 202.73 | 70.17 |
High | 90.14 | 829.78 | 164.52 | 206.02 | 70.35 |
Low | 87.67 | 817.43 | 162.91 | 201.59 | 69.18 |
Last | 89.23 | 822.51 | 163.71 | 205.29 | 69.30 |
Change | +1.63 | +0.84 | +0.58 | +2.57 | -0.86 |
% Change | +1.86% | +0.10% | +0.36% | +1.27% | -1.23% |
Volume | 12,393,400 | 2,125,000 | 5,760,500 | 6,478,200 | 5,867,000 |
20-Day Average Volume | 17,570,084 | 3,480,735 | 8,716,080 | 6,860,260 | 7,093,965 |
Previous Close | 87.60 | 821.67 | 163.13 | 202.72 | 70.16 |
Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
Has Options | Yes | Yes | Yes | Yes | Yes |
Technicals | |||||
20-Day Moving Average | 92.83 | 849.81 | 164.11 | 210.19 | 79.19 |
20-Day Raw Stochastic | 20.89% | 19.34% | 33.44% | 39.69% | 0.53% |
20-Day Relative Strength | 42.46% | 45.77% | 56.69% | 53.66% | 32.88% |
Weighted Alpha | -31.97 | +1.65 | +9.22 | +22.85 | -52.10 |
Today's Opinion | 88% Sell | 40% Sell | 72% Buy | 80% Buy | 100% Sell |
Previous Opinion | 88% Sell | 40% Sell | 72% Buy | 80% Buy | 100% Sell |
Last Month's Opinion | 88% Sell | 40% Buy | 40% Buy | 72% Buy | 56% Sell |
Performance | |||||
5-Days | |||||
%Chg | -4.17% since 03/21/25 | -1.80% since 03/21/25 | +0.05% since 03/21/25 | -2.25% since 03/21/25 | -9.84% since 03/21/25 |
Low | 87.08 on 03/25/25 | 815.29 on 03/27/25 | 160.55 on 03/25/25 | 196.49 on 03/26/25 | 69.18 on 03/28/25 |
High | 93.11 on 03/24/25 | 874.92 on 03/25/25 | 164.52 on 03/28/25 | 211.02 on 03/24/25 | 76.05 on 03/25/25 |
1-Month | |||||
%Chg | -3.27% since 02/28/25 | -10.66% since 02/28/25 | -0.79% since 02/28/25 | -1.79% since 02/28/25 | -23.55% since 02/28/25 |
Low | 87.08 on 03/25/25 | 795.38 on 03/13/25 | 160.55 on 03/25/25 | 196.49 on 03/26/25 | 69.18 on 03/28/25 |
High | 97.37 on 03/07/25 | 935.63 on 03/03/25 | 169.99 on 03/04/25 | 218.66 on 03/10/25 | 91.90 on 03/05/25 |
3-Month | |||||
%Chg | -10.50% since 12/27/24 | +5.02% since 12/27/24 | +12.86% since 12/27/24 | +15.32% since 12/27/24 | -20.68% since 12/27/24 |
Low | 81.04 on 02/18/25 | 725.01 on 01/17/25 | 140.68 on 01/10/25 | 168.06 on 01/22/25 | 69.18 on 03/28/25 |
High | 102.97 on 01/07/25 | 935.63 on 03/03/25 | 169.99 on 03/04/25 | 218.66 on 03/10/25 | 93.80 on 02/25/25 |
6-Month | |||||
%Chg | -21.51% since 09/27/24 | -6.30% since 09/27/24 | +1.43% since 09/27/24 | +5.39% since 09/27/24 | -42.61% since 09/27/24 |
Low | 81.04 on 02/18/25 | 711.40 on 11/18/24 | 140.68 on 01/10/25 | 163.81 on 11/19/24 | 69.18 on 03/28/25 |
High | 114.79 on 10/01/24 | 937.00 on 10/14/24 | 169.99 on 03/04/25 | 218.66 on 03/10/25 | 120.56 on 10/11/24 |
Key Statistics | |||||
Market Capitalization, $K | 221,280,736 | 779,082,816 | 393,118,464 | 358,607,232 | 314,845,280 |
Shares Outstanding, K | 2,526,036 | 948,170 | 2,409,848 | 1,768,978 | 4,487,532 |
Annual Sales | 64,168,000,000 | 45,042,700,000 | 88,821,000,000 | 56,334,000,000 | 42,108,430,000 |
Annual Net Income | 17,117,000,000 | 10,590,000,000 | 14,066,000,000 | 4,278,000,000 | 14,643,260,000 |
Last Quarter Sales | 15,624,000,000 | 13,532,800,000 | 22,520,000,000 | 15,102,000,000 | 12,261,320,000 |
Last Quarter Net Income | 3,743,000,000 | 4,409,800,000 | 3,431,000,000 | -22,000,000 | 4,026,620,000 |
60-Month Beta | 0.35 | 0.34 | 0.47 | 0.61 | 0.42 |
Per-Share Information | |||||
Most Recent Earnings | 1.72 on 02/04/25 | 5.32 on 02/06/25 | 2.04 on 01/22/25 | 2.16 on 01/31/25 | 0.91 on 02/05/25 |
Latest Earnings Date | 04/24/25 | 05/01/25 | 04/15/25 | 04/25/25 | 05/01/25 |
Most Recent Dividend | 0.810 on 03/17/25 | 1.500 on 02/14/25 | 1.240 on 02/18/25 | 1.640 on 01/15/25 | 0.787 on 03/31/25 |
Next Ex-Dividends Date | 03/17/25 | 02/14/25 | 02/18/25 | 04/15/25 | 03/31/25 |
Ratios | |||||
Price/Earnings ttm | 11.53 | 63.60 | 16.19 | 19.89 | 21.80 |